|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Nowadays the technology has rapidly advanced in the detection of mycobacterium tuberculosis and drug susceptibility clinical sample. The examination that include the advances microscopic, in viro-culture and application in molecular base. In developing countries the world health organization is played a role for evaluating and developing the technology of their efficiency, feasibility at present in India, natural network and designed microbiology centre, and also intermediate reference laboratories implemented by the revised national tuberculosis control programme RNTCP. Advance staining of sputum smears in microscopy technology that includes fluorescent microscopy and vital fluorescent. The turnaround time, if there is smear negative samples, and permits detection of resists mutants simultaneously. The detection of drug resistance in molecular base has reduced further TAT, and also the cartridge based nucleic acid tests with its convenience results, poised appears to become tuberculosis (TB) diagnosis provided, testing cost is reduce especially use of private diagnostic. This paper is reviews of recent technology adopted in diagnosis of TB.